|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 29, 2019 ) The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD 1.95 billion in 2018, at a CAGR of 7.4%. The major factors driving the growth of this market include the growing adoption of capsule formulations among the growing geriatric population, growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies.
By Type, Gelatin Capsules to Account for the Largest Market Share in 2018
On the basis of type, the gelatin capsules segment is expected to account for the largest share of the global empty capsules market in 2018. The various advantages associated with gelatin capsules, such as rapid drug release, uniform mixing of drugs, and a barrier to atmospheric oxygen (preventing oxidation of drug molecules), make them a preferred choice for manufacturing capsule shells.
Immediate-release Capsules Segment to Dominate the Empty Capsules Market, by Functionality, in 2018
Based on functionality, the empty capsules market is segmented into immediate-release, sustained-release, and delayed-release capsules. In 2018, the immediate-release capsules segment is estimated to account for the largest market share. This is because immediate-release capsules are widely used for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements. Also, immediate-release capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.
Antibiotic & Antibacterial Drugs to Account for the Largest Share of the Empty Capsules Market, by Application, in 2018
On the basis of application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations (hematinic), anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other applications. The antibiotic & antibacterial drugs segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the fact that antibiotic & antibacterial drugs are the most frequently prescribed drugs for the treatment of various diseases and disorders.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190
By End User, the Pharmaceutical Industry Segment Accounts for the Largest Market Share in 2018
Based on end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. In 2018, the pharmaceutical industry segment is estimated to account for the largest share of the empty capsules market. The increasing number of drugs launched as capsule formulations, growing prevalence of diseases for which capsule-based formulations form the primary treatment, and the rising demand for innovative drug delivery formulations are the key factors driving the growth of this segment.
North America to Dominate the Empty Capsules Market in 2018; This Trend to Continue During the Forecast Period
North America is expected to account for the largest share of the empty capsules market in 2018, followed by Europe and the Asia Pacific. The large share of North America can be attributed to the presence of major capsule manufacturers along with the presence of a number of pharmaceutical giants with large production capacities and the growing emphasis on superior pharmaceutical products and generics.
The prominent players in the global empty capsules market are Capsugel (US), ACG Worldwide (India), Qualicaps (Japan), Suheung Co. Ltd. (South Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd (China), Healthcaps India Ltd. (India), Snail Pharma Industry Co. Ltd. (China), Roxlor (US), Sunil Healthcare Ltd. (India), Medi-Caps Ltd. (India), Nectar Lifesciences Ltd. (India), Natural Capsules Ltd. (India), and Bright Pharma Caps Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Shelly Singh
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
